as on December 9, 2025 at 10:39 pm IST
Day's Low
Day's High
0.76%
Downside
1.53%
Upside
52 Week's Low
52 Week's High
15.27%
Downside
55.34%
Upside
Check Opko Health, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.1B
EPS (TTM)
-0.3277
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.13%
PE Ratio (TTM)
-4.56
Industry PE ratio
-0.4116938110749186
PEG Ratio
-2.87
EBITDA
-115.8M
Revenue (TTM)
642.1M
Profit Margin
-28.10%
Return On Equity TTM
-13.32%
Track how Opko Health, Inc. P/E has moved over time to understand its valuation trends.
Opko Health, Inc. in the last 5 years
Lowest (-134.91x)
December 31, 2021
Today (-4.56x)
December 9, 2025
Industry (-0.41x)
December 9, 2025
Highest (83.51x)
December 31, 2020
Today’s Price to Earnings Ratio: -4.56x
Compare market cap, revenue, PE, and other key metrics of Opko Health, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.1B | -71.3% | -4.56 | -28.10% | |
| BUY | $57.1B | 57.08% | 56.5 | 24.65% | |
| BUY | $38.5B | 32.68% | 31.07 | 8.07% | |
| BUY | $215.2B | 23.15% | 33.11 | 15.02% | |
| BUY | $41.2B | 22.37% | 31.84 | 18.75% |
The Opko Health, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Opko Health, Inc. investment value today
Current value as on today
₹88,774
Returns
Returns from Opko Health, Inc. Stock
Dollar Returns*
₹5,862 (+5.86%)
Based on 10 analysts
90.00%
Buy
10.00%
Hold
0.00%
Sell
Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Opko Health, Inc.. Average target price of $3.56
Get share price movements and forecasts by analysts on Opko Health, Inc..
What analysts predicted
63.2%UPSIDE
Target Price
$3.56
Current Price
$1.31
Analyzed by
10 Analysts
Target
$3.56
Opko Health, Inc. target price $3.56, a slight upside of 63.2% compared to current price of $1.31. According to 10 analysts rating.
Search interest for Opko Health, Inc. Stock has decreased by -10% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 29 October
Wed, 09:30 PM
-ModeX Therapeutics enters collaboration with Regeneron, receiving $7 million upfront and potential milestone payments exceeding $200 million per molecule.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -148.44M → 61.22M (in $), with an average increase of 342.4% per quarter
Against Peers
![]()
In the last 1 year, Idexx Laboratories, Inc. has given 56.8% return, outperforming this stock by 73.3%
Against Peers
![]()
In the last 3 years, Idexx Laboratories, Inc. has given 68.0% return, outperforming this stock by 68.8%
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 156.80M → 151.66M (in $), with an average decrease of 3.3% per quarter
Price Dip
![]()
In the last 7 days, OPK stock has moved down by -0.8%
| Organisation | Opko Health, Inc. |
| Headquarters | 4400 Biscayne Boulevard, Miami, FL, United States, 33137 |
| Industry | Health Technology |
| CEO | Dr. Phillip Frost M.D., Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Adam E. Logal | Senior VP & CFO |
Dr. Gary J. Nabel M.D., Ph.D. | Chief Information Officer & Director |
Mr. Giovanni Abbadessa M.D., Ph.D. | Chief Medical Officer of ModeX |
Dr. John R. Mascola M.D. | Chief Scientific Officer of ModeX |
Dr. Phillip Frost M.D., Ph.D. | Chairman & CEO |
Dr. Jane H. Hsiao M.B.A., Ph.D. | Vice Chairman & Chief Technical Officer |
Dr. Elias Adam Zerhouni M.D. | President & Vice Chairman |
Mr. Steven D. Rubin Esq., J.D. | Executive VP of Administration & Director |
Dr. Arie Gutman Ph.D. | President of API |
Dr. Akhtar Ashfaq FACP, FASN, M.D. | Senior Vice President of Clinical Research & Development and Medical Affairs - Opko Renal |
Opko Health, Inc. share price today is $1.31 as on . Opko Health, Inc. share today touched a day high of $1.33 and a low of $1.3.
Opko Health, Inc. share touched a 52 week high of $2.04 on and a 52 week low of $1.11 on . Opko Health, Inc. stock price today i.e. is trending at $1.31,which is 35.63% down from its 52 week high and 18.02% up from its 52 week low.
Opko Health, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Opko Health, Inc. (OPK) shares with as little as ₹89.831 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹898.31 in Opko Health, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Opko Health, Inc. share’s latest price of $1.31 as on December 9, 2025 at 10:39 pm IST, you will get 7.6336 shares of Opko Health, Inc.. Learn more about
fractional shares .
Opko Health, Inc. stock has given -71.3% share price returns and 22% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?